Injection: profile and news

Health Canada Approves Enbrel (Etanercept) for Psoriasis treatment Feb 9, 2006
...lesions have improved prospects for symptom-free remission, following the announcement that Health Canada has approved Enbrel® (etanercept), an innovative ... - DG News

Tumor Necrosis Factor- Mediates Diabetes-Enhanced Apoptosis of ... Feb 28, 2006
...we inoculated Porphyromonas gingivalis into the scalp of type 2 diabetic (db/db) or control mice and inhibited tumor necrosis factor (TNF- ) with etanercept. ... - Am J Pathology (subscription)

Rheumatoid Arthritis Drug Could Fight Problem Asthma Feb 16, 2006
Reducing the levels using a TNF-inhibiting drug, etanercept, reduced asthma symptoms in people with refractory -- hard to manage -- disease. ... - Forbes

Refractory Asthma May Respond to TNF-Alpha Inhibition Feb 16, 2006
Treatment for 10 weeks with the TNF-alpha inhibitor etanercept improved the signs and symptoms in those with refractory disease. ... - Medscape (subscription)

FDA Approves Rituxan for Refractory Rheumatoid Arthritis Mar 1, 2006
...for use in combination with methotrexate in patients with moderate-to-severe RA that has been refractory to treatment with Enbrel (etanercept) or Remicade ... - MedPage Today,

Genentech/Biogen Idec: Rituxan further expands its options Mar 2, 2006
...one or two traditional disease-modifying treatments (DMARDs), followed by the more expensive biologics such as Amgen's Enbrel (etanercept) or Johnson & ... - Pharmaceutical Business Review

Old News! Feb 28, 2006
My wife is on a Rheumatoid Arthritis medication which is a TNF receptor blocker called etanercept, trade name ENBREL, made by AMGEN, a division of Wyeth. ... - Joplin Independent,

FDA clears Rituxan for rheumatoid arthritis Mar 1, 2006
...responded to biologic therapy based on tumour necrosis factor blockers, namely Centocor's Remicade (infliximab), Amgen/Wyeth's Enbrel (etanercept) and Abbott ... - Pharma Times (subscription),

Genentech, Biogen Idec Gain Approval Of Rituxan In RA Mar 1, 2006
...an inadequate response or were intolerant to prior treatment with methotrexate and one or more TNF antagonist therapies such as Enbrel (etanercept, from Amgen ... - BioWorld Online (subscription),

Three-year studies on a novel therapy for rheumatoid arthritis ... Feb 22, 2006
England Journal of Medicine is that abatacept works very well even in those patients who have failed on other biologic agents, such as etanercept and infliximab ... - Canada NewsWire (press release),

Evidence of a Role of Tumor Necrosis Factor in Refractory Asthma Feb 15, 2006
We also investigated the effects of treatment with the soluble TNF- receptor etanercept (25 mg twice weekly) in the patients with refractory asthma in a placebo ... - New England Journal of Medicine (subscription),

Enbrel May Help Patients With Refractory Asthma Feb 15, 2006
LEICESTER, England - Asthma that is refractory to standard treatment with inhaled corticosteroids may respond to Enbrel (etanercept), a drug for rheumatoid ... - MedPage Today,

Protein levels predict bone marrow transplant survival Feb 19, 2006
...already FDA-approved and available on the market and she says they are currently conducting a clinical trial using one of these drugs, etanercept, in clinical ... - News-Medical.net,

BAMBOO SPINE, A SPECIAL KIND OF ARTHRITIS Feb 25, 2006
Pamidronate, a medicine used for osteoporosis, has also been found effective for AS; so have two newer drugs, infliximab and etanercept. DEAR DR. ... - Charlotte Sun-Herald,

New US Patent 6,982,089 Issued - Describing a Novel Biotechnology ... Feb 20, 2006
The patented methods involve the perispinal use of certain biologic inhibitors of TNF-alpha, including etanercept, certolizumab pegol (CDP 870), and others ... - PR Web (press release),

Rheumatic Diseases Remain a Significant Cause of Chronic Illness ... Feb 22, 2006
...tax credit and marketing incentives, and all three biologic TNF-inhibitors currently have orphan designation in the US but only Enbrel (etanercept) is approved ... - Business Wire (press release),

Protein Level Predicts Who Will Develop Deadly Complication Just ... Feb 21, 2006
We are currently conducting a clinical trial using one of these drugs, etanercept, in clinical trials to see if it can prevent or treat GVHD," says study ... - Medical News Today (press release),

European Medicines Agency: Committee for Medicinal Products for ... Feb 23, 2006
Enbrel (etanercept), from Wyeth Europe Ltd, to include an alternative dosing regimen of 50 mg once weekly, which will allow treatment of ankylosing spondylitis ... - PharmaLive.com (press release),

Better Fix For Rheumatoid Arthritis Feb 16, 2006
...which contribute to inflammation. Examples are etanercept, infliximab, adalimumab and anakinra. • Protein-A Immunoadsorption Therapy ... - WFtv.com,

American Journal of Clinical Nutrition, Vol. 83, No. 2, 475S-483S ... Feb 17, 2006
...and hierarchical role of these specific cytokines are shown by the fact that recombinant drugs that block the activity of either TNF- [etanercept (Enbrel; Amgen ... - Am J Clin Nutr (subscription),

Amgen Continues Manufacturing Expansion with Additional $1 Billion ... Feb 2, 2006
In 2005 Amgen opened an Enbrel(R) (etanercept) plant in Rhode Island, and announced plans to acquire Abgenix, Inc., a leading biopharmaceutical company with a ... - Genetic Engineering News,

Inflammatory Diseases - Both Chronic Diseases, Such as Rheumatoid ... Feb 1, 2006
CD). Nearly all sales were generated by the three available anti-TNF-a agents: etanercept, infliximab, and adalimumab. -- Twenty ... - Genetic Engineering News,

Health Canada Approves Enbrel (Etanercept) for Psoriasis treatment 09 Feb 2006
...lesions have improved prospects for symptom-free remission, following the announcement that Health Canada has approved Enbrel® (etanercept), an innovative ... - DG News

Rheumatoid arthritis: Etanercept and Methotrexate combination has ... Jan 21, 2006
TNF agent in patients with rheumatoid arthritis demonstrated that more than three quarters of patients treated with Enbrel ( Etanercept ) plus Methotrexate ... - Xagena.it,

Letter Warns of Hepatitis B Reactivation Associated with Anti-TNF ... Jan 18, 2006
...out a letter to health care professionals in consultation with Health Canada regarding their anti-TNF alpha products Enbrel (etanercept), Humira (adalimumab ... - DG News

Flu vaccine safe for arthritis patients Jan 26, 2006
RA patients, neither prednisone nor disease-modifying antirheumatic drugs (DMARDs) -- including methotrexate, infliximab and etanercept -- adversely affected ... - Reuters

New therapy offers hope for arthritis sufferers Jan 29, 2006
Currently, there are three "secret weapon" anti-TNF agents or DMARDs that can effectively block TNF molecules: etanercept (Enbrel), infliximab (Remicade) and ... - Daytona Beach News-Journal,

DTB recommends caution with new psoriatic arthritis drugs Jan 27, 2006
Leflunomide, etanercept, infliximab, and adalimumab are all licensed for the treatment of patients with arthritis in peripheral joints that is related to ... - Irish Medical News,

Better Fix for Rheumatoid Arthritis Feb 1, 2006
...which contribute to inflammation. Examples are etanercept, infliximab, adalimumab and anakinra. Protein-A Immunoadsorption Therapy ... - ABC7Chicago.com,

Amgen Revenues Up; Stock Drops Down On Data Delay Jan 26, 2006
...a 6 percent decrease from 2004; Neulasta (pegfilgrastim) and Neupogen (Filgrastim) sold $3.5 billion, a 20 percent increase; and Enbrel (etanercept) helped the ... - BioWorld Online (subscription),

Amgen slumps despite robust Q4 figures Jan 27, 2006
Epogen's decline was also counterbalanced by good gains for arthritis and psoriasis drug Enbrel (etanercept), which rose 19% to $674 million in the quarter, as ... - Pharma Times (subscription),

Amgen's Fourth Quarter 2005 Adjusted Earnings Per Share Increased ... Jan 26, 2006
Sales of Enbrel(R) (etanercept) increased 19 percent during the fourth quarter to $674 million versus $567 million during the same period in 2004. ... - Biotech Intelligence (press release),

Amgen to Make Significant Investment in Manufacturing, R&D and ... Jan 24, 2006
In 2005, Amgen received licensure of a NEUPOGEN ® (Filgrastim) and Neulasta ® (pegfilgrastim) plant in Puerto Rico and an Enbrel ® (etanercept) plant in ... - CCNMatthews (press release),

Amgen to Make Significant Investment in Manufacturing, R&D and ... Jan 24, 2006
In 2005, Amgen received licensure of a NEUPOGEN(R) (Filgrastim) and Neulasta(R) (pegfilgrastim) plant in Puerto Rico and an Enbrel(R) (etanercept) plant in ... - Business Wire (press release),